U.S. patent for Idaho Technology’s high resolution nucleic acid melting techniques

NewsGuard 100/100 Score

Idaho Technology’s patent portfolio continues to grow as the U.S. Patent and Trademark Office granted the company U.S. Patent No. 7,582,429 relating to methods of performing genetic analysis in the presence of a double-stranded nucleic acid binding dye.

This most recent patent is the latest in Idaho Technology’s high resolution melting patent family, and covers methods of using difference plots as a way of analyzing nucleic acid melting curves. This analysis method improves the resolution, through-put and ease of high resolution nucleic acid melting techniques and broadens its appeal for expanded use in gene scanning, mutation discovery, and genotyping applications.

The third patent to issue in the U.S. in the company’s high resolution melting patent portfolio, it strengthens Idaho Technology’s intellectual property beyond the existing methods and chemistry patents. In addition to this family of patents, Idaho Technology has extensive intellectual property holdings for many DNA analysis and amplification techniques. These techniques range from rapid thermocycling and real-time PCR to broadly used analysis methods and chemistry applications like SYBR® Green I-based PCR.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses